SCHEMBL10714770

SCHEMBL10714770

Cc1ccccc1-c1cc(C)c2c(c1)CC(=O)N2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA1 P42261 5/20 0.65
▸ CACNG8 Q8WXS5 5/20 0.65
▸ CACNG2 Q9Y698 1/20 0.49
▸ TDP2 O95551 6/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ CASP9 P55211 1/20 0.44
▸ CASP6 P55212 1/20 0.44
▸ CASP8 Q14790 1/20 0.44
▸ MAP3K14 Q99558 1/20 0.44
▸ GSK3B P49841 2/20 0.40
▸ CDK5 Q00535 2/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ NTRK1 P04629 1/20 0.40
▸ CSF1R P07333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10712589 0.86 GRIA1 (0.52) GRIA1CACNG8CACNG2TDP2CASP3
SCHEMBL18189620 0.83 GRIA1 (0.64) GRIA1CACNG8CACNG2TDP2GSK3B
SCHEMBL18189526 0.79 GRIA1 (0.45) GRIA1CACNG8CACNG2TDP2BRD4
SCHEMBL10714302 0.79 GRIA1 (1.00) GRIA1CACNG8TDP2GSK3BCDK5
SCHEMBL18189510 0.78 GRIA1 (0.60) GRIA1CACNG8CACNG2TDP2GSK3B
SCHEMBL18189507 0.77 GRIA1 (0.57) GRIA1CACNG8CACNG2TDP2GSK3B
SCHEMBL18189528 0.77 GRIA1 (0.69) GRIA1CACNG8CACNG2TDP2ABL1
SCHEMBL10711238 0.76 CYP19A1 (0.45) GRIA1CACNG8TDP2CASP3CASP7
SCHEMBL5782680 0.76 GRIA1 (0.78) GRIA1CACNG8TDP2CASP3CASP7
SCHEMBL22904264 0.75 GRIA1 (0.68) GRIA1CACNG8TDP2CASP3CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4670566-A ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-06-02 — — US disclosed
US-4440785-A Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation A. H. ROBINS COMPANY, INC. (US) 1984-04-03 — — US disclosed
Send feedback